U.S. Hospitals May ‘Recalculate’ How They Report COVID Cases
Perhaps influenced by the lifting of COVID-19-related restrictions by several European countries—starting with Denmark—during the past two weeks, the United States seems to be on the verge of following Europe’s lead in declaring the pandemic over. In a recent interview with the Financial Times, White House chief medical advisor and director of the National Institute […]
Myocarditis Risk Following mRNA COVID Shots May Be Far Higher Than Previously Estimated
A new study conducted by researchers from the U.S. Centers for Disease Control and Prevention (CDC) and several universities and hospitals in the United States shows that the risk of myocarditis (inflammation of the heart muscle) after receiving a messenger RNA (mRNA) COVID-19 biologic is 133 times greater than the normal risk for the condition […]
Study Finds SARS-CoV-2 Much Less Infectious After 20 Minutes in Air
A new study conducted by the University of Bristol Aerosol Research Centre in the United Kingdom found that the SARS-CoV-2 virus loses 90 percent of its virulence within 20 minutes after being exhaled into the air. Further, researchers concluded that the virus loses 50 percent of its ability to spread after only 10 minutes of […]
Novavax’s Protein COVID-19 Vaccine Now Available in Europe
Novavax’s experimental NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine has been authorized for distribution in the European Union (E.U.), making it the fifth COVID vaccine available for use in the E.U. Approved for people over 18 years old, Nuvaxoid is the first protein subunit COVID vaccine to be approved for use.1 2 The […]
Treatment Protocols for COVID-19: An Overview
Two years into the global pandemic of the novel coronavirus SARS-CoV-2, there is scant guidance from government agencies, universities, or professional medical organizations to help individuals recover from the SARS-CoV-2 infection that causes COVID-19 without the need for hospitalization. The U.S. Centers for Disease Control and Prevention (CDC), which recommends monoclonal antibodies for high-risk individuals […]
“Fully Vaccinated” Doesn’t Mean What It Used to Mean
On Dec. 8, 2021, the White House’s chief medical advisor, Anthony Fauci, MD, suggested he believed it was likely the U.S. government would change the definition of what it meant to be “fully vaccinated” to include booster shots, as well as the original two-shot regimen of the Pfizer/BioNTech and Moderna/NIAID COVID-19 biologics or one shot […]
New York Times Deputy Editor Dies of Heart Attack Day After Getting Moderna COVID Shot
The deputy Asia editor for The New York Times, Carlos Tejada, died in a hospital in Seoul, South Korea on Dec. 17, 2021, the day after reportedly getting a booster shot of Moderna/NIAID’s experimental messenger RNA (mRNA) mRNA-1273 (also known as “Spikevax”) biologic.1 2 3 4 According to his wife, 49-year-old Tejada died of a […]
Young Man in New Zealand Dies of Myocarditis 12 Days After Getting Pfizer COVID Biologic
A 26-year-old man in Dunedin, New Zealand died on Nov. 17, 2021 unexpectedly, 12 days after getting the first dose of Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 (also known as “Comirnaty”) biologic for COVID-19. Rory James Nairn was vaccinated on Nov. 5 and reportedly began to feel heart palpations or “flutters” a few hours after […]
CDC Opts for mRNA Biologics Over J&J COVID Vaccine Following Nine Blood Clotting Deaths
Based on concerns over a growing number of reports of a blood clotting disorder known as thrombosis with thrombocytopenia syndrome (TTS) following vaccination with Johnson & Johnson/Janssen’s experimental human adenovirus vectored Ad26.COV2.S vaccine, the Advisory Committee on Immunization Practices (ACIP) voted 15-0 on Dec. 16, 2021 to recommend the experimental messenger RNA (mRNA) COVID-19 biologics […]
Pfizer Says Fourth COVID Shot May Be Needed, Fauci Talks About Annual Shots
In an interview with CNBC on Dec. 8, 2021, Pfizer CEO Albert Bourla said that he expects sooner rather than later all Americans will have to get a fourth dose of Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 biologic for COVID-19 to try to protect against the Omicron variant of the SARS-CoV-2 virus causing mostly mild COVID disease. […]
